We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-0.2%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.11B
AUM Growth
-$61.8M
Cap. Flow
-$52.1M
Cap. Flow %
-4.71%
Top 10 Hldgs %
53.45%
Holding
46
New
1
Increased
8
Reduced
27
Closed
1

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$28.6M
2
MSFT icon
Microsoft
MSFT
+$2.87M
3
MDT icon
Medtronic
MDT
+$2.8M
4
PG icon
Procter & Gamble
PG
+$2.72M
5
KO icon
Coca-Cola
KO
+$2.66M

Sector Composition

Rank Sector Weight
1 Technology 34.13%
2 Industrials 17.57%
3 Healthcare 16.19%
4 Consumer Staples 15.15%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.45T
$76.8M 6.94%
2,651,980
-65,200
-2% -$1.85M
MSFT icon
2
Microsoft
MSFT
$3.74T
$74.2M 6.71%
1,193,888
-47,777
-4% -$2.87M
RTX icon
3
RTX Corp
RTX
$302B
$63.7M 5.76%
923,522
+610
+0.1% +$40.4K
ORCL icon
4
Oracle
ORCL
$419B
$61.9M 5.59%
1,609,203
-17,355
-1% -$679K
WMT icon
5
Walmart Inc
WMT
$901B
$60.2M 5.45%
2,614,380
-71,799
-3% -$1.68M
CSCO icon
6
Cisco
CSCO
$475B
$58M 5.24%
1,918,852
-44,658
-2% -$1.36M
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.11T
$55M 4.97%
337,343
+3,866
+1% +$595K
CHRW icon
8
C.H. Robinson
CHRW
$17B
$50.5M 4.56%
688,859
-5,426
-0.8% -$393K
NVO
9
Novo Nordisk
NVO
$207B
$45.5M 4.11%
2,537,530
+140,132
+6% +$2.54M
PG icon
10
Procter & Gamble
PG
$338B
$45.5M 4.11%
541,063
-31,917
-6% -$2.72M
VAR
11
DELISTED
Varian Medical Systems, Inc.
VAR
$42.5M 3.84%
539,250
-18,112
-3% -$1.47M
BDX icon
12
Becton Dickinson
BDX
$49.4B
$37.7M 3.41%
233,350
-15,467
-6% -$2.57M
CTSH icon
13
Cognizant
CTSH
$26.4B
$36.8M 3.33%
657,043
+8,346
+1% +$447K
IBM icon
14
IBM
IBM
$225B
$35.7M 3.23%
224,929
-4,104
-2% -$625K
BIIB icon
15
Biogen
BIIB
$30.1B
$34.1M 3.08%
120,326
-2,246
-2% -$666K
ACN icon
16
Accenture
ACN
$110B
$33.4M 3.02%
285,090
-16,077
-5% -$1.91M
MMM icon
17
3M
MMM
$94.4B
$33.1M 2.99%
221,652
-9,201
-4% -$1.33M
JNJ icon
18
Johnson & Johnson
JNJ
$626B
$31.4M 2.84%
272,651
-22,108
-8% -$2.55M
KO icon
19
Coca-Cola
KO
$372B
$30.8M 2.78%
742,262
-63,982
-8% -$2.66M
PEP icon
20
PepsiCo
PEP
$189B
$30.1M 2.72%
287,806
-14,376
-5% -$1.51M
EXPD icon
21
Expeditors International
EXPD
$23B
$29.7M 2.69%
560,996
+12,954
+2% +$677K
MDT icon
22
Medtronic
MDT
$116B
$29.4M 2.66%
413,211
-35,622
-8% -$2.8M
PII icon
23
Polaris
PII
$3.99B
$25.1M 2.27%
304,151
-17,455
-5% -$1.42M
NKE icon
24
Nike
NKE
$61.3B
$21.6M 1.95%
425,113
-5,355
-1% -$275K
OMC icon
25
Omnicom Group
OMC
$23.6B
$17.6M 1.59%
206,403
-12,301
-6% -$1.03M

Similar funds

Saratoga Research & Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Saratoga Research & Investment Management held 46 positions worth $1.11B, down 5.3% from $1.17B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Saratoga Research & Investment Management withdrew a net $52.1M in Q4 2016, closing 1 position and reducing 27 holdings. Its most notable exit was Sysco, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Saratoga Research & Investment Management opened a new position in Walt Disney worth $3.55M.

  • Saratoga Research & Investment Management's largest Q4 2016 buy was Walt Disney: 34,082 shares worth $3.55M.
  • Saratoga Research & Investment Management added most to Novo Nordisk in Q4 2016, an estimated $2.54M increase.
  • Saratoga Research & Investment Management's biggest Q4 2016 reduction was Microsoft, cutting an estimated $2.87M.
  • Saratoga Research & Investment Management fully exited Sysco in Q4 2016, selling an estimated $28.6M.
  • Saratoga Research & Investment Management's ten largest holdings make up 53% of its $1.11B portfolio in Q4 2016.
  • Saratoga Research & Investment Management opened 1 new position and closed 1 in Q4 2016.
  • Saratoga Research & Investment Management's portfolio value fell 5.3% quarter-over-quarter to $1.11B.

Based on Saratoga Research & Investment Management's 13F filing for Q4 2016, filed 18 Jan 2017.